Bonferroni testing showed that BDNF mRNA levels were significantly reduced in BPD (P=0.008; 26% reduction), schizophrenia (P=0.008; 27% reduction) and MDD (P=0.0005; 34% reduction) compared with controls (Figure 3d). This evidence concerns the gene BDNF and major depressive disorder.